TCM
BSX icon

TD Capital Management’s Boston Scientific BSX Stock Holding History

TD Capital Management’s Portfolio BSX Stock Details BSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.07K Sell
72
-49
-40% -$2.66K ﹤0.01% 598
2026
Q1 		$7.59K Buy
121
+27
+29% +$2.16K ﹤0.01% 504
2025
Q4 		$8.96K Hold
94
– – ﹤0.01% 461
2025
Q3 		$9.18K Hold
94
– – ﹤0.01% 434
2025
Q2 		$10.1K Hold
94
– – ﹤0.01% 413
2025
Q1 		$9.48K Hold
94
– – ﹤0.01% 314
2024
Q4 		$8.4K Buy
94
+45
+92% +$3.96K ﹤0.01% 300
2024
Q3 		$4.11K Buy
+49
New +$3.86K ﹤0.01% 356
2024
Q2 		– Sell
-12
Closed -$822 – 449
2024
Q1 		$822 Buy
+12
New +$772 ﹤0.01% 422

Other funds holding BSX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

TD Capital Management's BSX Position: Q2 2026 in Review

TD Capital Management reduced its Boston Scientific (BSX) stake by 40% in Q2 2026, selling an estimated $2.66K and leaving 72 shares worth $3.07K. The position accounts for ﹤0.01% of the portfolio, ranked #598.

TD Capital Management first reported a position in BSX in Q1 2024 and has held it in 9 quarters since. The position peaked at $10.1K in Q2 2025. 1,477 funds tracked by Wall St. Rank hold BSX as of Q2 2026.

  • TD Capital Management held 72 shares of Boston Scientific worth $3.07K as of Q2 2026.
  • TD Capital Management sold 49 Boston Scientific shares in Q2 2026, an estimated $2.66K.
  • Boston Scientific made up ﹤0.01% of TD Capital Management's portfolio in Q2 2026, its #598 holding.
  • TD Capital Management first reported a position in Boston Scientific in Q1 2024 and has held it in 9 quarters since.
  • TD Capital Management's Boston Scientific position peaked at $10.1K in Q2 2025.
  • 1,477 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.

Based on TD Capital Management's 13F filing for Q2 2026, filed 6 Aug 2026.